FeNO measurement is a validated non-invasive technique, which is used for diagnosis and monitoring of asthma. It would be desirable to find a reliable method to monitor allergic rhinitis (AR) via measurement of FeNO, and/or nasal nitric oxide (nNO). The aim of our study was the assessment of the efficacy of FeNO and nNO as markers in AR treatment. FeNO and nNO were measured with the portable NO analyser (NIOX MINO®) in healthy participants and in patients with AR. The patients were examined during the pollen season and out of it. The effect of local corticosteroids and antihistamine therapy was observed in patients with AR during pollen season after three weeks of therapy. There are significant differences between FeNO and nNO in patients with AR compared to healthy controls at all set points of measurements. While FeNO responded well to the treatment with both antihistamines and combined therapy, nNO decreased only after combined therapy with antihistamines and nasal corticosteroids. nNO monitoring alone is not a suitable method to monitor inflammation of the upper airways in AR and its suppression by anti-allergic treatment and should be correlated with other markers as FeNO or symptom scores.

BioMed Martin Division of Respirology Comenius University in Bratislava Jessenius Faculty of Medicine in Martin Slovak

Zobrazit více v PubMed

ALVING K, WEITZBERG E, LUNDBERG JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J. 1993;6:1368–1370. PubMed

ANTOSOVA M, MOKRA D, PEPUCHA L, PLEVKOVA J, BUDAY T, STERUSKY M, BENCOVA A. Physiology of nitric oxide in the respiratory system. Physiol Res. 2017a;66(Suppl 2):S159–S172. doi: 10.33549/physiolres.933673. PubMed DOI

ANTOSOVA M, MOKRA D, TONHAJZEROVA I, MIKOLKA P, KOSUTOVA P, MESTANIK M, PEPUCHA L, PLEVKOVA J, BUDAY T, CALKOVSKY V, BENCOVA A. Nasal nitric oxide in healthy adults - reference values and affecting factors. Physiol Res. 2017b;66(Suppl 2):S247–S255. doi: 10.33549/physiolres.933680. PubMed DOI

ATS/ERS Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med. 2005;2005;171:912–930. doi: 10.1164/rccm.200406-710ST. PubMed DOI

ARNAL JF, DIDIER A, RAMI J, M’RINI C, CHARLET JP, SERRANO E, BESOMBES JP. Nasal nitric oxide is increased in allergic rhinitis. Clin Exp Allergy. 1997;27:358–362. doi: 10.1111/j.1365-2222.1997.tb00719.x. PubMed DOI

BACHERT C, van CAUWENBERGE P, KHALTAEV N, BOUSQUET J WORLD HEALTH ORGANIZATION. Allergic rhinitis and its impact on asthma. Allergy. 2002;57:841–855. doi: 10.1034/j.1398-9995.2002.23625.x. PubMed DOI

BALBI B, PIGNATTI P, CORRADI M, BAIARDI P, BIANCHI L, BRUNETTI G, RADAELI A, MOSCATO G, MUTTI A, SPANEVELLO A, MALERBA M. Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults. Eur Respir J. 2007;30:769–781. doi: 10.1183/09031936.00112306. PubMed DOI

BASYIGIT I, YILDIZ F, OZKARA SK, BOYACI H, ILGAZLI A. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients. Mediators Inflamm. 2004;13:285–291. doi: 10.1080/09629350400003118. PubMed DOI PMC

BERGMANN-HUG K, WIRTH R, HENSELER M, HELBLING A, PICHLER WJ, SCHNYDER B. Effect of natural seasonal pollen exposure and repeated nasal allergen provocations on elevation of exhaled nitric oxide. Allergy. 2009;64:1629–1634. doi: 10.1111/j.1398-9995.2009.02087.x. PubMed DOI

CORREN J. The impact of allergic rhinitis on bronchial asthma. J Allergy Clin Immunol. 1998;101:S352–356. doi: 10.1016/S0091-6749(98)70218-0. PubMed DOI

DOWNIE SR, ANDERSSON M, RIMMER J, LEUPPI JD, XUAN W, AKERLUND A, PEAT JK, SALOME CM. Association between nasal and bronchial symptoms in subjects with persistent allergic rhinitis. Allergy. 2004;59:320–326. doi: 10.1111/j.1398-9995.2003.00419.x. PubMed DOI

GRATZIOU C, ROVINA N, LIGNOS M, VOGIATZIS I, ROUSSOS C. Exhaled nitric oxide in seasonal allergic rhinitis: influence of pollen season and therapy. Clin Exp Allergy. 2001;31:409–416. doi: 10.1046/j.1365-2222.2001.01001.x. PubMed DOI

HENRIKSEN AH, SUE-CHU M, HOLMEN TL, LANGHAMMER A, BJERMER L. Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur Respir J. 1999;13:301–306. doi: 10.1034/j.1399-3003.1999.13b14.x. PubMed DOI

JATAKANON A, LIM S, KHARITONOV SA, CHUNG KF, BARNES PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax. 1998;53:91–95. doi: 10.1136/thx.53.2.91. PubMed DOI PMC

JILMA B, KASTNER J, MENSIK C, VONDROVEC B, HILDEBRANDT J, KREJCY K, WAGNER OF, EICHLER HG. Sex differences in concentrations of exhaled nitric oxide and plasma nitrate. Life Sci. 1996;58:469–476. doi: 10.1016/0024-3205(95)02311-9. PubMed DOI

JORISSEN M, LEFEVERE L, WILLEMS T. Nasal nitric oxide. Allergy. 2001;56:1026–1033. doi: 10.1034/j.1398-9995.2001.00145.x. PubMed DOI

KHARITONOV S, ALVING K, BARNES PJ. Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J. 1997;10:1683–1693. doi: 10.1183/09031936.97.10071683. PubMed DOI

KROUSE JH, ROLAND PS, MARPLE BF, WALL GM, HANNLEY M, GOLLA S, HUNSAKER D. Optimal duration of allergic rhinitis clinical trials. Otolaryngol Head Neck Surg. 2005;133:467–487. doi: 10.1016/j.otohns.2005.07.024. PubMed DOI

LEE KJ, CHO SH, LEE SH, TAE K, YOON HJ, KIM SH, JEONG JH. Nasal and exhaled nitric oxide in allergic rhinitis. Clin Exp Otorhinolaryngol. 2012;5:228–233. doi: 10.3342/ceo.2012.5.4.228. PubMed DOI PMC

LEIGH MW, HAZUCHA MJ, CHAWLA KK, BAKER BR, SHAPIRO AJ, BROWN DE, LAVANGE LM, HORTON BJ, QAQISH B, CARSON JL, DAVIS SD, DELL SD, FERKOL TW, ATKINSON JJ, OLIVIER KN, SAGEL SD, ROSENFELD M, MILLA C, LEE HS, KRISCHER J, ZARIWALA MA, KNOWLES MR. Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia. Ann Am Thorac Soc. 2013;10:574–581. doi: 10.1513/AnnalsATS.201305-110OC. PubMed DOI PMC

LINHARES D, JACINTO T, PEREIRA AM, FONSECA JA. Effects of atopy and rhinitis on exhaled nitric oxide values - a systematic review. Clin Transl Allergy. 2011;1:8. doi: 10.1186/2045-7022-1-8. PubMed DOI PMC

LUNDBERG JO, RINDER J, WEITZBERG F, ALVING K, LUNDBERG JM. Heavy physical exercise decreases nitric oxide levels in the nasal airways in humans. Acta Physiol Scand. 1997;159:51–57. doi: 10.1046/j.1365-201X.1997.68339000.x. PubMed DOI

MANISCALCO M, SOFIA M, CARRATÙ L, HIGENBOTTAM T. Effect of nitric oxide inhibition on nasal airway resistance after nasal allergen challenge in allergic rhinitis. Eur J Clin Invest. 2001;31:462–466. doi: 10.1046/j.1365-2362.2001.00825.x. PubMed DOI

NAVARRO A, VALERO A, ROSALES MJ, MULLOL J. Clinical use of oral antihistamines and intranasal corticosteroids in patients with allergic rhinitis. J Investig Allergol Clin Immunol. 2011;21:363–369. PubMed

OLIN AC, HELLGREN J, KARLSSON G, LJUNGKVIST G, NOLKRANTZ K, TORÉN K. Nasal nitric oxide and its relationship to nasal symptoms, smoking and nasal nitrate. Rhinology. 1998;36:117–121. PubMed

OLTHOFF A, ROHRBACH S, FABER M, GÖTZ W, LASKAWI R. Neuronal nitric oxide synthase immunoreactivity in the nasal mucosa of patients with idiopathic and allergic rhinitis. ORL J Otorhinolaryngol Relat Spec. 2002;64:180–185. doi: 10.1159/000058022. PubMed DOI

PALM JP, ALVING K, LUNDBERG JO. Characterization of airway nitric oxide in allergic rhinitis: the effect of intranasal administration of L-NAME. Allergy. 2003;58:885–892. doi: 10.1034/j.1398-9995.2003.00098.x. PubMed DOI

POLOSA R, CIAMARRA I, MANGANO G, PROSPERINI G, PISTORIO MP, VANCHERI C, CRIMI N. Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis. Eur Respir J. 2000;15:30–35. doi: 10.1183/09031936.00.15103000. PubMed DOI

SERRANO C, VALERO A, PICADO C. Nasal nitric oxide (in Spanish) Arch Bronconeumol. 2004;40:222–230. doi: 10.1157/13060347. PubMed DOI

STRUBEN VMD, WIERINGA MH, FEENSTRA L, DE JONGSTE JC. Nasal nitric oxide and nasal allergy. Allergy. 2006;61:665–670. doi: 10.1111/j.1398-9995.2006.01096.x. PubMed DOI

TAYLOR DR, PIJNENBURG MW, SMITH AD, de JONGSTE JC. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax. 2006;61:817–827. doi: 10.1136/thx.2005.056093. PubMed DOI PMC

WANG D-Y. Treatment of allergic rhinitis: H1-antihistamines and intranasal steroids. Curr Drug Targets Inflamm Allergy. 2002;1:215–220. doi: 10.2174/1568010023344625. PubMed DOI

WILLIAMSON PA, VAIDYANATHAN S, CLEARIE K, STEWART M, LIPWORTH BJ. Relationship between fractional exhaled nitric oxide and nasal nitric oxide in airways disease. Ann Allergy Asthma Immunol. 2010;105:162–167. doi: 10.1016/j.anai.2010.05.014. PubMed DOI

WILSON AM, DEMPSEY OJ, SIMS EJ, LIPWORTH BJ. Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2000;85:111–114. doi: 10.1016/S1081-1206(10)62449-0. PubMed DOI

YAMADA T, YAMAMOTO H, KUBO S, SAKASHITA M, TOKUNAGA T, SUSUKI D, NARITA N, OGI K, KANNO M, YAMASHITA S, TERASAWA Y, KAYANO Y, MASADA M, FUJIEDA S. Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis. Allergy Asthma Proc. 2012;33:e9–16. doi: 10.2500/aap.2012.33.3509. PubMed DOI

YUKSEL H, KIRMAZ C, YILMAZ O, PINAR E, VATANSEVER S, DEGIRMENCI PB, OZBILGIN K. Nasal mucosal expression of nitric oxide synthases in patients with allergic rhinitis and its relation to asthma. Ann Allergy Asthma Immunol. 2008;100:12–16. doi: 10.1016/S1081-1206(10)60398-5. PubMed DOI

Legacy of Prof. Juraj Korpáš: International Impact of Slovak School of Experimental Respirology